SUITABILITY OF A NETWORK META-ANALYSIS OF TARGETED SYNTHETIC OR BIOLOGIC THERAPY FOR PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE BIOLOGIC DMARDS

被引:0
|
作者
Peterson, S. [1 ]
Alfonso-Cristancho, R. [2 ]
Pacou, M. [3 ]
Belhadi, D. [3 ]
Van Sanden, s [4 ]
Webb, T. [1 ]
Ganguly, R. [5 ]
Kurrasch, R. [5 ]
Rao, R. [6 ]
Hsu, B. [1 ]
Popik, S. [1 ]
Jansen, J. P. [7 ]
机构
[1] Janssen Res & Dev LLC, Spring House, PA USA
[2] GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA
[3] Amaris, Paris, France
[4] Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium
[5] GlaxoSmithKline, Collegeville, PA USA
[6] GSK Med Res Ctr, Stevenage, Herts, England
[7] Precis Hlth Econ, Oakland, CA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMS6
引用
收藏
页码:A141 / A141
页数:1
相关论文
共 50 条
  • [21] Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs
    Kalweit, Maria
    Burden, Andrea. M. H.
    Boedecker, Joschka
    Hugle, Thomas H.
    Burkard, Theresa
    PLOS COMPUTATIONAL BIOLOGY, 2023, 19 (06)
  • [22] Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study
    Russell, Mark D.
    Yang, Zijing
    Dooley, Niamh
    Gibson, Mark
    Zuckerman, Benjamin
    Adas, Maryam A.
    Alveyn, Edward
    Patel, Samir
    Bechman, Katie
    Price, Elizabeth
    Gallagher, Sarah
    Coalwood, Callum
    Cope, Andrew P.
    Norton, Sam
    Galloway, James B.
    RHEUMATOLOGY, 2024,
  • [23] Safety of Biologic & Targeted Therapies Among Elderly Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
    Sood, Akhil
    Al Snih, Soham
    Murthy, Vijaya
    Gonzalez, Emilio
    Raji, Mukaila
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry
    Lin, Ching-Tsai
    Huang, Wen-Nan
    Tsai, Wen-Chan
    Chen, Jun-Peng
    Hung, Wei-Ting
    Hsieh, Tsu-Yi
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lai, Kuo-Lung
    Tang, Kuo-Tung
    Tseng, Chih-Wei
    Chen, Der-Yuan
    Chen, Yi-Hsin
    Chen, Yi-Ming
    PLOS ONE, 2021, 16 (04):
  • [25] Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Biologic and Non-Biologic Dmards
    Maro, Judith
    Menzin, Talia
    Hornbuckle, Kenneth
    Giles, Jon T.
    Kavanaugh, Arthur
    Doerner, Thomas
    Martin, David
    Huang, Jane
    Salinas, Claudia A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [26] RISK OF VENOUS THROMBOEMBOLISM IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC AND NON-BIOLOGIC DMARDS
    Maro, J. C.
    Menzin, T.
    Hornbuckle, K.
    Giles, J. T.
    Kavanaugh, A.
    Doerner, T.
    Martin, D.
    Huang, T.
    Salinas, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 932 - 932
  • [27] Changing Patterns of Use of Biologic/Targeted Synthetic DMARDs in Psoriatic Arthritis: An Analysis of the OPAL Dataset
    Ciciriello, Sabina
    Smith, Tegan
    Littlejohn, Geoffrey
    Tymms, Kathleen
    Mathers, David
    Cooley, Helen
    Griffiths, Hedley
    OSullivan, Catherine
    Youssef, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] UPTAKE OF NEWER BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS, RESULTS FROM FOUR NORDIC BIOLOGIC REGISTRIES
    Glintborg, B.
    Di Giuseppe, D.
    Wallman, J. K.
    Nordstrom, D.
    Gudbjornsson, B.
    Hetland, M. L.
    Askling, J.
    Grondal, G.
    Sokka-Isler, T.
    Provan, S. Aarrestad
    Lindstrom, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 766 - 767
  • [29] EFFECTS OF BIOLOGIC DMARDS ON PHYSICAL FUNCTION IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF NETWORK META-ANALYSES
    Ruyssen-Witrand, A.
    Sapin, C.
    Hartz, S.
    Leage, S. Liu
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 363 - 364
  • [30] Network meta-analysis of tofacitinib versus biologic treatments in moderate-to-severe rheumatoid arthritis patients
    Camean-Castillo, Manuel
    Gimeno-Ballester, Vicente
    Rios-Sanchez, Esmeralda
    Fenix-Caballero, Silvia
    Vazquez-Real, Miguel
    Alegre-del Rey, Emilio
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (03) : 384 - 396